SCHEMBL23914409

SCHEMBL23914409

C=C1C(=O)O[C@H](c2cccc(OC)c2)[C@@H]1c1ccc(C#N)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.42
ALDH1A1 P00352 7/20 0.41
MEN1 O00255 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40
RAB9A P51151 2/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HIF1A Q16665 2/20 0.40
KDM4E B2RXH2 2/20 0.40
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
NFKB1 P19838 1/20 0.40
HTT P42858 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
GSK3B P49841 1/20 0.40
NR3C2 P08235 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23914329 0.88 NPBWR1 (0.40) GRM5ALDH1A1MEN1CYP3A4CYP2D6
SCHEMBL23913787 0.88 KDM1A (0.46) ALDH1A1MEN1CYP3A4RAB9AKMT2A
SCHEMBL23913799 0.82 ALDH1A1 (0.43) ALDH1A1MEN1CYP3A4KMT2AKDM4E
SCHEMBL23914441 0.82 CYP2C19 (0.48) GRM5ALDH1A1MEN1CYP3A4CYP2D6
SCHEMBL23914310 0.81 MAPK1 (0.37) ALDH1A1MEN1KMT2ASMN1; SMN2MAPK1
SCHEMBL23913796 0.81 MEN1 (0.40) ALDH1A1MEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL23913791 0.81 TNKS (0.40) ALDH1A1MEN1RAB9AKMT2AKDM4E
SCHEMBL23914431 0.81 TNKS (0.40) ALDH1A1MEN1RAB9AKMT2AKDM4E
SCHEMBL23914279 0.78 ALDH1A1 (0.46) ALDH1A1KDM1A
SCHEMBL23913790 0.78 ALDH1A1 (0.46) ALDH1A1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317099-A1 SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS PURDUE RESEARCH FOUNDATION (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317099-A1 SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS MIF, LTA, MGAM GRM5 2038/4885ALDH1A1 2164/4885MEN1 1587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.